Sun Pharma acquires stake in Krystal Biotech Inc.
DSIJ Intelligence / 14 Aug 2017
All the formalities for the acquisition of 2,03,136 Series A Preferred Stock (15.91% fully diluted stake) of Krystal Biotech Inc. have been concluded by Sun Pharmaceutical Industries.
All the formalities for the acquisition of 2,03,136 Series A Preferred Stock (15.91% fully diluted stake) of Krystal Biotech Inc. have been concluded by Sun Pharmaceutical Industries.
Following this information filed with the BSE, the stock has recovered from its intraday losses and entered the green zone. It was trading at Rs 452.60 per share, up by Rs 0.90 or 0.20% as at 1139 hours on Monday, on the BSE. The stock has hit an intraday high and low of Rs 456.70 and Rs 433.15 respectively.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.